1. Home
  2. RELX vs COR Comparison

RELX vs COR Comparison

Compare RELX & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RELX PLC PLC

RELX

RELX PLC PLC

N/A

Current Price

$34.19

Market Cap

53.2B

ML Signal

N/A

Logo Cencora Inc.

COR

Cencora Inc.

N/A

Current Price

$352.73

Market Cap

68.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RELX
COR
Founded
1903
2001
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Business Services
Other Pharmaceuticals
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2B
68.5B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
RELX
COR
Price
$34.19
$352.73
Analyst Decision
Buy
Buy
Analyst Count
2
13
Target Price
N/A
$395.23
AVG Volume (30 Days)
4.2M
897.1K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
2.49%
0.69%
EPS Growth
N/A
5.71
EPS
N/A
2.87
Revenue
N/A
$321,332,819,000.00
Revenue This Year
$9.17
$8.97
Revenue Next Year
$6.23
$6.76
P/E Ratio
$20.27
$121.86
Revenue Growth
N/A
9.31
52 Week Low
$27.57
$252.49
52 Week High
$56.33
$377.54

Technical Indicators

Market Signals
Indicator
RELX
COR
Relative Strength Index (RSI) 50.09 44.67
Support Level $27.57 $331.73
Resistance Level $41.06 $353.18
Average True Range (ATR) 0.82 7.32
MACD 0.44 -2.26
Stochastic Oscillator 70.43 13.53

Price Performance

Historical Comparison
RELX
COR

About RELX RELX PLC PLC

RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.

About COR Cencora Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: